Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction

Background Meso-Rex bypass is used to treat patients with clinically important extrahepatic portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is used to bypass the portal blood circulation from the superior mesenteric vein to the left portal vein. Other vascula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery 2009-04, Vol.145 (4), p.406-410
Hauptverfasser: Facciuto, Marcelo E., MD, Rodriguez-Davalos, Manuel I., MD, Singh, Manoj K., MD, Rocca, Juan P., MD, Rochon, Caroline, MD, Chen, Wei, MD, Katta, Umadevi S., MD, Sheiner, Patricia A., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 410
container_issue 4
container_start_page 406
container_title Surgery
container_volume 145
creator Facciuto, Marcelo E., MD
Rodriguez-Davalos, Manuel I., MD
Singh, Manoj K., MD
Rocca, Juan P., MD
Rochon, Caroline, MD
Chen, Wei, MD
Katta, Umadevi S., MD
Sheiner, Patricia A., MD
description Background Meso-Rex bypass is used to treat patients with clinically important extrahepatic portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is used to bypass the portal blood circulation from the superior mesenteric vein to the left portal vein. Other vascular conduits have included the autogenous saphenous vein, splenic vein, right gastroepiploic vein, and inferior mesenteric vein. Methods A total of 20 umbilical veins with attached livers were harvested from 20 deceased liver donors. Umbilical veins were dilated mechanically and checked for patency and communication with the left portal vein. Vein length and diameter after dilatation were recorded. Cross-sections of 15 recanalized umbilical veins were processed by routine histologic examination and stained with hematoxylin and eosin, as well as processed by immunohistochemistry for CD31 and factor VIII antigens. Subsequently, 3 children with EHPVO underwent this modified meso-Rex bypass using the umbilical vein as a vascular conduit. Results The mean length of harvested umbilical veins was 15 cm (range, 7–21); the mean length of recanalized and usable umbilical veins was 10 cm (range, 5–15). Recanalization was successful in 16 (80%) of the 20 donor umbilical veins. The mean diameter of the umbilical veins after serial dilatation and recanalization was 1.2 cm (range, 1–2). In 11 (73%) of the 15 recanalized vein specimens, the lumen was lined by endothelial cells. In 2 children, the vascular conduit was constructed entirely with native umbilical vein. In the remaining child, 3 cm of umbilical vein was preserved and anastomosed to a mobilized inferior mesenteric vein due to inadequate length. All 3 children had patent bypass and resolution of clinical manifestations of portal hypertension at a mean follow-up of 21 months. Conclusion Meso-Rex bypass may prove to be a definitive treatment for patients with EHPVO. The use of native umbilical vein as a vein conduit achieved decompression of the splanchnic venous system and should be considered a natural alternative to other interposition vein grafts.
doi_str_mv 10.1016/j.surg.2008.12.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67051912</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606009000038</els_id><sourcerecordid>67051912</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-a8e3a6ff09c1286372c436627168d575cda55dabc42a907808686fa8d0252c023</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi1ERbeFF-CAcoFbwtjeOI6EkFBFAalSpRauWI4zAS9JHDxJ1eXpcbQLSBx6msN8_2j0_Yw951Bw4Or1rqAlfisEgC64KAC2j9iGl1LklVT8MdsAyDpXoOCUnRHtAKDecv2EnfJappWuN-zrDTo72t7_wjZbhsb33tk-u0M_Zi6M7eLnrAsxG5BCfoP3WbOfLFGW1ng_R_sdJzt7l00hzn9yoaE5Lm72YXzKTjrbEz47znP25fL954uP-dX1h08X765yV0I551ajtKrroHZcaCUr4bZSKVFxpduyKl1ry7K1jdsKW0OlQSutOqtbEKVwIOQ5e3W4O8Xwc0GazeDJYd_bEcNCRlVQ8pqvoDiALgaiiJ2Zoh9s3BsOZrVqdma1alarhguTrKbQi-P1pRmw_Rc5akzAyyNgKenroh2dp7-c4CJRXCfuzYHD5OLOYzTkPI4OWx_RzaYN_uE_3v4Xd70f18J-4B5pF5aYqiTDDaWAuV37X-uHOlUPUsvfMgOrFw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67051912</pqid></control><display><type>article</type><title>Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Facciuto, Marcelo E., MD ; Rodriguez-Davalos, Manuel I., MD ; Singh, Manoj K., MD ; Rocca, Juan P., MD ; Rochon, Caroline, MD ; Chen, Wei, MD ; Katta, Umadevi S., MD ; Sheiner, Patricia A., MD</creator><creatorcontrib>Facciuto, Marcelo E., MD ; Rodriguez-Davalos, Manuel I., MD ; Singh, Manoj K., MD ; Rocca, Juan P., MD ; Rochon, Caroline, MD ; Chen, Wei, MD ; Katta, Umadevi S., MD ; Sheiner, Patricia A., MD</creatorcontrib><description>Background Meso-Rex bypass is used to treat patients with clinically important extrahepatic portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is used to bypass the portal blood circulation from the superior mesenteric vein to the left portal vein. Other vascular conduits have included the autogenous saphenous vein, splenic vein, right gastroepiploic vein, and inferior mesenteric vein. Methods A total of 20 umbilical veins with attached livers were harvested from 20 deceased liver donors. Umbilical veins were dilated mechanically and checked for patency and communication with the left portal vein. Vein length and diameter after dilatation were recorded. Cross-sections of 15 recanalized umbilical veins were processed by routine histologic examination and stained with hematoxylin and eosin, as well as processed by immunohistochemistry for CD31 and factor VIII antigens. Subsequently, 3 children with EHPVO underwent this modified meso-Rex bypass using the umbilical vein as a vascular conduit. Results The mean length of harvested umbilical veins was 15 cm (range, 7–21); the mean length of recanalized and usable umbilical veins was 10 cm (range, 5–15). Recanalization was successful in 16 (80%) of the 20 donor umbilical veins. The mean diameter of the umbilical veins after serial dilatation and recanalization was 1.2 cm (range, 1–2). In 11 (73%) of the 15 recanalized vein specimens, the lumen was lined by endothelial cells. In 2 children, the vascular conduit was constructed entirely with native umbilical vein. In the remaining child, 3 cm of umbilical vein was preserved and anastomosed to a mobilized inferior mesenteric vein due to inadequate length. All 3 children had patent bypass and resolution of clinical manifestations of portal hypertension at a mean follow-up of 21 months. Conclusion Meso-Rex bypass may prove to be a definitive treatment for patients with EHPVO. The use of native umbilical vein as a vein conduit achieved decompression of the splanchnic venous system and should be considered a natural alternative to other interposition vein grafts.</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2008.12.004</identifier><identifier>PMID: 19303989</identifier><identifier>CODEN: SURGAZ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Cadaver ; Child ; Child, Preschool ; Female ; General aspects ; Humans ; Hypertension, Portal - surgery ; Liver - blood supply ; Liver - pathology ; Male ; Medical sciences ; Middle Aged ; Portal Vein ; Portasystemic Shunt, Surgical - methods ; Surgery ; Umbilical Veins - pathology ; Umbilical Veins - surgery ; Young Adult</subject><ispartof>Surgery, 2009-04, Vol.145 (4), p.406-410</ispartof><rights>Mosby, Inc.</rights><rights>2009 Mosby, Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-a8e3a6ff09c1286372c436627168d575cda55dabc42a907808686fa8d0252c023</citedby><cites>FETCH-LOGICAL-c505t-a8e3a6ff09c1286372c436627168d575cda55dabc42a907808686fa8d0252c023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0039606009000038$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21298918$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19303989$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Facciuto, Marcelo E., MD</creatorcontrib><creatorcontrib>Rodriguez-Davalos, Manuel I., MD</creatorcontrib><creatorcontrib>Singh, Manoj K., MD</creatorcontrib><creatorcontrib>Rocca, Juan P., MD</creatorcontrib><creatorcontrib>Rochon, Caroline, MD</creatorcontrib><creatorcontrib>Chen, Wei, MD</creatorcontrib><creatorcontrib>Katta, Umadevi S., MD</creatorcontrib><creatorcontrib>Sheiner, Patricia A., MD</creatorcontrib><title>Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Background Meso-Rex bypass is used to treat patients with clinically important extrahepatic portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is used to bypass the portal blood circulation from the superior mesenteric vein to the left portal vein. Other vascular conduits have included the autogenous saphenous vein, splenic vein, right gastroepiploic vein, and inferior mesenteric vein. Methods A total of 20 umbilical veins with attached livers were harvested from 20 deceased liver donors. Umbilical veins were dilated mechanically and checked for patency and communication with the left portal vein. Vein length and diameter after dilatation were recorded. Cross-sections of 15 recanalized umbilical veins were processed by routine histologic examination and stained with hematoxylin and eosin, as well as processed by immunohistochemistry for CD31 and factor VIII antigens. Subsequently, 3 children with EHPVO underwent this modified meso-Rex bypass using the umbilical vein as a vascular conduit. Results The mean length of harvested umbilical veins was 15 cm (range, 7–21); the mean length of recanalized and usable umbilical veins was 10 cm (range, 5–15). Recanalization was successful in 16 (80%) of the 20 donor umbilical veins. The mean diameter of the umbilical veins after serial dilatation and recanalization was 1.2 cm (range, 1–2). In 11 (73%) of the 15 recanalized vein specimens, the lumen was lined by endothelial cells. In 2 children, the vascular conduit was constructed entirely with native umbilical vein. In the remaining child, 3 cm of umbilical vein was preserved and anastomosed to a mobilized inferior mesenteric vein due to inadequate length. All 3 children had patent bypass and resolution of clinical manifestations of portal hypertension at a mean follow-up of 21 months. Conclusion Meso-Rex bypass may prove to be a definitive treatment for patients with EHPVO. The use of native umbilical vein as a vein conduit achieved decompression of the splanchnic venous system and should be considered a natural alternative to other interposition vein grafts.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cadaver</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Hypertension, Portal - surgery</subject><subject>Liver - blood supply</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Portal Vein</subject><subject>Portasystemic Shunt, Surgical - methods</subject><subject>Surgery</subject><subject>Umbilical Veins - pathology</subject><subject>Umbilical Veins - surgery</subject><subject>Young Adult</subject><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhi1ERbeFF-CAcoFbwtjeOI6EkFBFAalSpRauWI4zAS9JHDxJ1eXpcbQLSBx6msN8_2j0_Yw951Bw4Or1rqAlfisEgC64KAC2j9iGl1LklVT8MdsAyDpXoOCUnRHtAKDecv2EnfJappWuN-zrDTo72t7_wjZbhsb33tk-u0M_Zi6M7eLnrAsxG5BCfoP3WbOfLFGW1ng_R_sdJzt7l00hzn9yoaE5Lm72YXzKTjrbEz47znP25fL954uP-dX1h08X765yV0I551ajtKrroHZcaCUr4bZSKVFxpduyKl1ry7K1jdsKW0OlQSutOqtbEKVwIOQ5e3W4O8Xwc0GazeDJYd_bEcNCRlVQ8pqvoDiALgaiiJ2Zoh9s3BsOZrVqdma1alarhguTrKbQi-P1pRmw_Rc5akzAyyNgKenroh2dp7-c4CJRXCfuzYHD5OLOYzTkPI4OWx_RzaYN_uE_3v4Xd70f18J-4B5pF5aYqiTDDaWAuV37X-uHOlUPUsvfMgOrFw</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Facciuto, Marcelo E., MD</creator><creator>Rodriguez-Davalos, Manuel I., MD</creator><creator>Singh, Manoj K., MD</creator><creator>Rocca, Juan P., MD</creator><creator>Rochon, Caroline, MD</creator><creator>Chen, Wei, MD</creator><creator>Katta, Umadevi S., MD</creator><creator>Sheiner, Patricia A., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090401</creationdate><title>Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction</title><author>Facciuto, Marcelo E., MD ; Rodriguez-Davalos, Manuel I., MD ; Singh, Manoj K., MD ; Rocca, Juan P., MD ; Rochon, Caroline, MD ; Chen, Wei, MD ; Katta, Umadevi S., MD ; Sheiner, Patricia A., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-a8e3a6ff09c1286372c436627168d575cda55dabc42a907808686fa8d0252c023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cadaver</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Hypertension, Portal - surgery</topic><topic>Liver - blood supply</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Portal Vein</topic><topic>Portasystemic Shunt, Surgical - methods</topic><topic>Surgery</topic><topic>Umbilical Veins - pathology</topic><topic>Umbilical Veins - surgery</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Facciuto, Marcelo E., MD</creatorcontrib><creatorcontrib>Rodriguez-Davalos, Manuel I., MD</creatorcontrib><creatorcontrib>Singh, Manoj K., MD</creatorcontrib><creatorcontrib>Rocca, Juan P., MD</creatorcontrib><creatorcontrib>Rochon, Caroline, MD</creatorcontrib><creatorcontrib>Chen, Wei, MD</creatorcontrib><creatorcontrib>Katta, Umadevi S., MD</creatorcontrib><creatorcontrib>Sheiner, Patricia A., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Facciuto, Marcelo E., MD</au><au>Rodriguez-Davalos, Manuel I., MD</au><au>Singh, Manoj K., MD</au><au>Rocca, Juan P., MD</au><au>Rochon, Caroline, MD</au><au>Chen, Wei, MD</au><au>Katta, Umadevi S., MD</au><au>Sheiner, Patricia A., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>145</volume><issue>4</issue><spage>406</spage><epage>410</epage><pages>406-410</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><coden>SURGAZ</coden><abstract>Background Meso-Rex bypass is used to treat patients with clinically important extrahepatic portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is used to bypass the portal blood circulation from the superior mesenteric vein to the left portal vein. Other vascular conduits have included the autogenous saphenous vein, splenic vein, right gastroepiploic vein, and inferior mesenteric vein. Methods A total of 20 umbilical veins with attached livers were harvested from 20 deceased liver donors. Umbilical veins were dilated mechanically and checked for patency and communication with the left portal vein. Vein length and diameter after dilatation were recorded. Cross-sections of 15 recanalized umbilical veins were processed by routine histologic examination and stained with hematoxylin and eosin, as well as processed by immunohistochemistry for CD31 and factor VIII antigens. Subsequently, 3 children with EHPVO underwent this modified meso-Rex bypass using the umbilical vein as a vascular conduit. Results The mean length of harvested umbilical veins was 15 cm (range, 7–21); the mean length of recanalized and usable umbilical veins was 10 cm (range, 5–15). Recanalization was successful in 16 (80%) of the 20 donor umbilical veins. The mean diameter of the umbilical veins after serial dilatation and recanalization was 1.2 cm (range, 1–2). In 11 (73%) of the 15 recanalized vein specimens, the lumen was lined by endothelial cells. In 2 children, the vascular conduit was constructed entirely with native umbilical vein. In the remaining child, 3 cm of umbilical vein was preserved and anastomosed to a mobilized inferior mesenteric vein due to inadequate length. All 3 children had patent bypass and resolution of clinical manifestations of portal hypertension at a mean follow-up of 21 months. Conclusion Meso-Rex bypass may prove to be a definitive treatment for patients with EHPVO. The use of native umbilical vein as a vein conduit achieved decompression of the splanchnic venous system and should be considered a natural alternative to other interposition vein grafts.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19303989</pmid><doi>10.1016/j.surg.2008.12.004</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-6060
ispartof Surgery, 2009-04, Vol.145 (4), p.406-410
issn 0039-6060
1532-7361
language eng
recordid cdi_proquest_miscellaneous_67051912
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Cadaver
Child
Child, Preschool
Female
General aspects
Humans
Hypertension, Portal - surgery
Liver - blood supply
Liver - pathology
Male
Medical sciences
Middle Aged
Portal Vein
Portasystemic Shunt, Surgical - methods
Surgery
Umbilical Veins - pathology
Umbilical Veins - surgery
Young Adult
title Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A34%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recanalized%20umbilical%20vein%20conduit%20for%20meso-Rex%20bypass%20in%20extrahepatic%20portal%20vein%20obstruction&rft.jtitle=Surgery&rft.au=Facciuto,%20Marcelo%20E.,%20MD&rft.date=2009-04-01&rft.volume=145&rft.issue=4&rft.spage=406&rft.epage=410&rft.pages=406-410&rft.issn=0039-6060&rft.eissn=1532-7361&rft.coden=SURGAZ&rft_id=info:doi/10.1016/j.surg.2008.12.004&rft_dat=%3Cproquest_cross%3E67051912%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67051912&rft_id=info:pmid/19303989&rft_els_id=S0039606009000038&rfr_iscdi=true